<DOC>
	<DOCNO>NCT01364246</DOCNO>
	<brief_summary>Multiple sclerosis ( MS ) classically regard chronic inflammatory autoimmune demyelinate disease central nervous system , along considerable pathological heterogeneity . Neuromyelitis optica ( NMO ) severe inflammatory , demyelinate disease , clinical characteristic include recurrent optic neuritis longitudinally extensive transverse myelitis . Current therapy provide modest control progressive Multiple Sclerosis Neuromyelitis Optica.Stem cell therapy might open light horizon approach efficient treatment progressive MS NMO . In study , safety efficacy Human Umbilical Cord Mesenchymal Stem Cells transplantation evaluate patient progressive MS NMO .</brief_summary>
	<brief_title>Safety Efficacy Umbilical Cord Mesenchymal Stem Cell Therapy Patients With Progressive Multiple Sclerosis Neuromyelitis Optica</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Neuromyelitis Optica</mesh_term>
	<criteria>McDonald Diagnosis Multiple Sclerosis 2006 Diagnosis neuromyelitis optica . Aged 1665 year . Disease duration≥2years Poor response steroid therapy . Written inform consent follow clinic trail procedure Cardiac insufficiency ; Renal insufficiency ; hepatic insufficiency ; Total bilirubin high 1.5 time upper limit normal value ; AST /ALT high 2.5 time upper limit normal value . Combined Pneumonia Severe systemic bacteria infection . Severe drug allergic history anaphylaxis 2 food medicine . Intracranial hypertension dues Other brain lesion ( eg . Brain cancer ) / HIV+ , TPPA +， patient diagnose HBV HCV . Tumor Markers + Severe psychotic patient , cognitive dysfunction , Or understand sign Consent Form . Coagulation disorder . Uncontrolled hypertension treatment，blood pressure≥180mmHg/110 mmHg . Pregnancy . Enrollment trial last 3 month . Other criterion investigator consider improper inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Progressive Multiple Sclerosis</keyword>
	<keyword>neuromyelitis optica</keyword>
	<keyword>Umbilical Cord Mesenchymal Stem Cell</keyword>
</DOC>